celiprolol has been researched along with Heart Disease, Ischemic in 5 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celiprolol is a selective beta(1)-adrenoceptor antagonist with antihypertensive actions, which causes renal vasodilation by increasing tissue nitric oxide (NO) levels." | 5.32 | Celiprolol increases coronary blood flow and reduces severity of myocardial ischemia via nitric oxide release. ( Asakura, M; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Minamino, T; Node, K; Ogita, H; Sakata, Y; Sanada, S; Tada, M; Takashima, S; Ueda, Y, 2003) |
| "Celiprolol is a selective beta(1)-adrenoceptor antagonist with antihypertensive actions, which causes renal vasodilation by increasing tissue nitric oxide (NO) levels." | 1.32 | Celiprolol increases coronary blood flow and reduces severity of myocardial ischemia via nitric oxide release. ( Asakura, M; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Minamino, T; Node, K; Ogita, H; Sakata, Y; Sanada, S; Tada, M; Takashima, S; Ueda, Y, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanuma, H | 1 |
| Node, K | 1 |
| Minamino, T | 1 |
| Sanada, S | 1 |
| Takashima, S | 1 |
| Ueda, Y | 1 |
| Sakata, Y | 1 |
| Asakura, M | 1 |
| Kim, J | 1 |
| Ogita, H | 1 |
| Tada, M | 1 |
| Hori, M | 1 |
| Kitakaze, M | 1 |
| Fejfar, Z | 1 |
| Vrána, M | 1 |
| Schweizer, J | 1 |
| Kaulen, R | 1 |
| Nierade, A | 1 |
| Altmann, E | 1 |
| Owens, P | 1 |
| O'Brien, E | 1 |
| Iagenskiĭ, AV | 1 |
| Barsukov, BP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "PGDT With the Hypotension Prediction Index to Reduce the Number and Duration of Intraoperative Hypotension and the Incidence of Renal Failure in Patients Undergoing Lung Surgery"[NCT04149314] | 142 participants (Actual) | Interventional | 2019-11-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for celiprolol and Heart Disease, Ischemic
| Article | Year |
|---|---|
[The third generation of b-blockers: new possibilities ].
Topics: Adrenergic beta-Antagonists; Asthma; Celiprolol; Hemodynamics; Humans; Hypertension; Lipoproteins, H | 1992 |
1 trial available for celiprolol and Heart Disease, Ischemic
| Article | Year |
|---|---|
Beta-blockers and nitrates in patients with peripheral arterial occlusive disease: long-term findings.
Topics: Adrenergic beta-Antagonists; Aged; Arterial Occlusive Diseases; Atenolol; Blood Flow Velocity; Celip | 1997 |
3 other studies available for celiprolol and Heart Disease, Ischemic
| Article | Year |
|---|---|
Celiprolol increases coronary blood flow and reduces severity of myocardial ischemia via nitric oxide release.
Topics: Animals; Celiprolol; Coronary Circulation; Dogs; Enzyme Inhibitors; Myocardial Ischemia; Nitric Oxid | 2003 |
Dogs at high or low risk of ventricular fibrillation. An experimental study of acute myocardial ischaemia.
Topics: Acute Disease; Animals; Cardiac Pacing, Artificial; Celiprolol; Dogs; Flunitrazepam; Heart Rate; Mal | 1993 |
Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Blood Pressure Monitoring, Amb | 1999 |